Sign Up to like & get
recommendations!
1
Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-lb-259
Abstract: Objective: The peptide receptor radionuclide therapy (PPRT) for somatostatin receptor positive (SSTR) neuroendocrine tumors (NETs) has emerged more than 15 years ago. The beta-emitter-PRRT has shown to induce objective response in 30-45% of metastatic NETs…
read more here.
Keywords:
tumors nets;
rmx;
image guided;
neuroendocrine tumors ... See more keywords